AU5225693A - Human monoclonal antibodies to human immunodeficiency virus - Google Patents

Human monoclonal antibodies to human immunodeficiency virus

Info

Publication number
AU5225693A
AU5225693A AU52256/93A AU5225693A AU5225693A AU 5225693 A AU5225693 A AU 5225693A AU 52256/93 A AU52256/93 A AU 52256/93A AU 5225693 A AU5225693 A AU 5225693A AU 5225693 A AU5225693 A AU 5225693A
Authority
AU
Australia
Prior art keywords
human
monoclonal antibodies
immunodeficiency virus
human immunodeficiency
human monoclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU52256/93A
Other versions
AU680836B2 (en
Inventor
Miroslaw K. Gorny
Susan Zolla-Pazner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York University NYU
Original Assignee
New York University NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York University NYU filed Critical New York University NYU
Publication of AU5225693A publication Critical patent/AU5225693A/en
Application granted granted Critical
Publication of AU680836B2 publication Critical patent/AU680836B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU52256/93A 1989-02-28 1993-12-08 Human monoclonal antibodies to human immunodeficiency virus Ceased AU680836B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US409986 1982-08-20
US31674489A 1989-02-28 1989-02-28
US40998689A 1989-09-19 1989-09-19
US316744 1994-10-03

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU51885/90A Division AU651794B2 (en) 1989-02-28 1990-02-28 Human monoclonal antibodies to human immunodeficiency virus

Publications (2)

Publication Number Publication Date
AU5225693A true AU5225693A (en) 1994-03-03
AU680836B2 AU680836B2 (en) 1997-08-14

Family

ID=26980569

Family Applications (2)

Application Number Title Priority Date Filing Date
AU51885/90A Ceased AU651794B2 (en) 1989-02-28 1990-02-28 Human monoclonal antibodies to human immunodeficiency virus
AU52256/93A Ceased AU680836B2 (en) 1989-02-28 1993-12-08 Human monoclonal antibodies to human immunodeficiency virus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU51885/90A Ceased AU651794B2 (en) 1989-02-28 1990-02-28 Human monoclonal antibodies to human immunodeficiency virus

Country Status (5)

Country Link
EP (1) EP0418347A4 (en)
JP (1) JPH04505099A (en)
AU (2) AU651794B2 (en)
CA (1) CA2028121A1 (en)
WO (1) WO1990009805A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033915A1 (en) 1996-03-12 1997-09-18 Ovoimmun Gmbh Avian, vitellin antibodies directed against hiv antigens
DE19809785C2 (en) * 1998-03-08 2000-02-10 Wolfgang Bergter Radioimmune drug for the treatment of HIV-1 infection
FR2777285B1 (en) * 1998-04-10 2000-05-19 Bio Merieux PEPTIDE LIGAND WITH SPECIFIC AFFINITY TO HIV-1 RETROVIRUS P24 PROTEIN
EP1765398B1 (en) 2004-06-01 2011-07-13 Merck Sharp & Dohme Corp. Human antibodies interacting with hiv gp41
CN108779168A (en) 2015-12-05 2018-11-09 沃迪奥斯大学医院中心 HIV bonding agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8705522A1 (en) * 1984-10-18 1987-05-01 Pasteur Institut Gag antigen and its use for the detection of lav infection and in immunogenic compositions
DK169582B1 (en) * 1986-06-23 1994-12-12 Squibb Bristol Myers Co Human monoclonal antibody capable of reacting with an epitope on the LAV / HTLV-III envelope glycoprotein gp41, cell lines producing such antibody, pharmaceutical preparation containing the antibody, and method for determining the presence of LAV / HTLV-III in a biological sample. and method for separating specific antigenic determinants of LAV / HTLV-III using ant

Also Published As

Publication number Publication date
CA2028121A1 (en) 1990-08-29
EP0418347A1 (en) 1991-03-27
AU651794B2 (en) 1994-08-04
AU5188590A (en) 1990-09-26
EP0418347A4 (en) 1994-12-14
AU680836B2 (en) 1997-08-14
WO1990009805A1 (en) 1990-09-07
JPH04505099A (en) 1992-09-10

Similar Documents

Publication Publication Date Title
EP0777497A4 (en) Human neutralizing monoclonal antibodies to human immunodeficiency virus
AU1085488A (en) Monoclonal antibodies to a pan-malarial antigen
AU5267190A (en) Modified antibodies
GB2196634B (en) Monoclonal antibodies to hiv and related peptides
AU5999490A (en) Chimeric antibodies directed against a human glycoprotein antigen
AU1107188A (en) Monoclonal antibodies to glycopeptides of human cytomegalovirus
GB2186592B (en) Cross-protective human monoclonal antibody compositions
AU7203194A (en) Bispecific human monoclonal antibodies specific for human immunodeficiency virus
IL94624A0 (en) Human monoclonal antibodies to hiv-1 mn qq120
AU7160691A (en) Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes
KR960001503B1 (en) Method for rdetecting antibodies to human immunodeficiency virus
AU5435990A (en) Monoclonal antibodies to human glutathione s transferase pi
AU680836B2 (en) Human monoclonal antibodies to human immunodeficiency virus
AU2383288A (en) Human anti-rh(d) monoclonal antibodies
AU7649187A (en) Preparation of monoclonal antibodies
AU7632787A (en) Monoclonal antibodies to chlorinated dibenzo-p-dioxins
AU1820692A (en) Novel anti-hiv antibodies
AU3432389A (en) Human monoclonal antibodies against rabies virus
AU618720B2 (en) Monoclonal antibodies
AU1676288A (en) Human immunodeficiency virus gag-encoded proteins
AU4576689A (en) Peptides which bind to hiv-2 specific antibody
AU2521288A (en) Human anti-rh(d) monoclonal antibodies
IE902008L (en) HUMAN MONOCLONAL ANTIBODIES TO HIV-IMN gp120
AU6964891A (en) Novel monoclonal antibody against human platelets
AU2389588A (en) Human anti-rh(d) monoclonal antibodies

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired